These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2777372)

  • 1. Intraperitoneal host cellular responses and in vivo killing of Bacteroides fragilis in a bacterial containment chamber.
    Onderdonk AB; Cisneros RL; Crabb JH; Finberg RW; Kasper DL
    Infect Immun; 1989 Oct; 57(10):3030-7. PubMed ID: 2777372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model.
    Onderdonk AB; Markham RB; Zaleznik DF; Cisneros RL; Kasper DL
    J Clin Invest; 1982 Jan; 69(1):9-16. PubMed ID: 6976357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune reactions to Bacteroides fragilis populations with three different types of capsule in a model of infection.
    Patrick S; Lutton DA; Crockard AD
    Microbiology (Reading); 1995 Aug; 141 ( Pt 8)():1969-1976. PubMed ID: 7551059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a model of intraabdominal sepsis for studies of the pathogenicity of Bacteroides fragilis.
    Onderdonk AB; Shapiro ME; Finberg RW; Zaleznik DF; Kasper DL
    Rev Infect Dis; 1984; 6 Suppl 1():S91-5. PubMed ID: 6372042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular immunity to Bacteroides fragilis capsular polysaccharide.
    Shapiro ME; Onderdonk AB; Kasper DL; Finberg RW
    J Exp Med; 1982 Apr; 155(4):1188-97. PubMed ID: 6174672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Escherichia coli and Bacteroides fragilis on peritoneal host defenses.
    Dunn DL; Barke RA; Ewald DC; Simmons RL
    Infect Immun; 1985 May; 48(2):287-91. PubMed ID: 3886544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune mechanisms in the prevention of intra-abdominal abscess formation.
    Kasper DL; Finberg RF; Crabb J; Onderdonk AB
    Scand J Infect Dis Suppl; 1989; 62():29-34. PubMed ID: 2587962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The growth and survival of capsulate and non-capsulate Bacteroides fragilis in vivo and in vitro.
    Patrick S; Reid JH; Larkin MJ
    J Med Microbiol; 1984 Jun; 17(3):237-46. PubMed ID: 6726783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of opsonins for Bacteroides fragilis in immune sera collected from experimentally infected mice.
    Ellis TM; Barrett JT
    Infect Immun; 1982 Mar; 35(3):929-36. PubMed ID: 7068222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of phagocytosis of E. coli by B. fragilis group--an in vitro study.
    Beena VK; Kumari N; Shivananda PG
    Indian J Pathol Microbiol; 1997 Jul; 40(3):373-6. PubMed ID: 9354011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in opsonophagocytic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: effect of capsular polysaccharide.
    Simon GL; Klempner MS; Kasper DL; Gorbach SL
    J Infect Dis; 1982 Jan; 145(1):72-7. PubMed ID: 7054319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism.
    Chung DR; Kasper DL; Panzo RJ; Chitnis T; Grusby MJ; Sayegh MH; Tzianabos AO
    J Immunol; 2003 Feb; 170(4):1958-63. PubMed ID: 12574364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination patterns of Escherichia coli and bacteroides fragilis from the peritoneal cavity. Studies with experimental peritonitis in pigs.
    Nyström PO; Skau T
    Acta Chir Scand; 1983; 149(4):383-8. PubMed ID: 6351520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phagocytic and serum killing of capsulate and non-capsulate Bacteroides fragilis.
    Reid JH; Patrick S
    J Med Microbiol; 1984 Jun; 17(3):247-57. PubMed ID: 6726784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis.
    Kasper DL; Onderdonk AB; Crabb J; Bartlett JG
    J Infect Dis; 1979 Nov; 140(5):724-31. PubMed ID: 528789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal model system for studying virulence of and host response to Bacteroides fragilis.
    Onderdonk AB; Cisneros RL; Finberg R; Crabb JH; Kasper DL
    Rev Infect Dis; 1990; 12 Suppl 2():S169-77. PubMed ID: 2406869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence of Bacteroides fragilis in vivo.
    Onderdonk AB; Moon NE; Kasper DL; Bartlett JG
    Infect Immun; 1978 Mar; 19(3):1083-7. PubMed ID: 640723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro activity of peritoneal cells from rats after intra-abdominal infection with Bacteroides fragilis and Escherichia coli.
    Verweij WR; Namavar F; Schouten WF; Kostense PJ; Pellenkoft M; De Graaff J; MacClaren DM
    J Med Microbiol; 1993 Jan; 38(1):13-8. PubMed ID: 8380297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrin in peritonitis. IV. Synergistic intraperitoneal infection caused by Escherichia coli and Bacteroides fragilis within fibrin clots.
    Dunn DL; Rotstein OD; Simmons RL
    Arch Surg; 1984 Feb; 119(2):139-44. PubMed ID: 6365029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of anti-Bacteroides-antibodies on Escherichia coli and different Bacteroides species in vitro and vivo.
    Rodloff AC; Hilliger F; Friedman H; Hahn H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Nov; 262(4):483-91. PubMed ID: 3541458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.